Controlling Blood Pressure in 50% of All Hypertensive Patients: An Achievable Goal in the Healthy People 2010 Report?

Abstract

Background

One important objective defined in the Healthy People 2010 report was to improve blood pressure (BP) control to < 140/90 mm Hg in 50% of all hypertensive patients. Because the US population is becoming older, more obese, and ethnically diverse, the health and economic benefits of reaching this goal become more valuable each year. Hypertension control rates are currently at ∼ 31% of all hypertensives and have risen slowly and erratically since 1988. In the absence of a coordinated strategic plan, achieving this critically important goal for BP control is highly unlikely.

Methods

A selected literature review was undertaken to briefly assess the cardiovascular benefits of controlling hypertension. Greater focus was placed on variables that impact hypertension awareness, treatment, and control. The impact on hypertension control rates of theoretic changes in awareness, treatment, and control individually and collectively was examined. Four categories of potential barriers to optimizing BP control are discussed: systems, provider, patient, and treatment factors.

Results

Raising awareness to 80% of all hypertensives, ensuring treatment of 90% of aware hypertensives, and controlling BP to < 140/90 mm Hg in 70% of treated patients would achieve control rates of 50%.

Conclusions

The barriers to achieving the Healthy People 2010 goal of controlling hypertension in 50% of all patients are formidable but appear to be resolvable with a coordinated strategic plan. Given projected demographic changes in the United States, the health and economic benefits of attaining the national goal for hypertension control would seem to merit a serious integrated effort.

Keywords

Healthy People 2010 hypertension high blood pressure

References

Hajjar

, Kotchen

T.A.

Trends in prevalence, awareness, treatment, and control of hypertension in the United States, 1988–2000.

JAMA 2003; 290: 199–206.

Healthy People 2010: US Government Printing Office No. 017-001-00547-9. Available at: http://www.healthypeople.gov/publications (accessed July 2003).

Moser

, Hebert

P.R.

Prevention of disease progression, left ventricular hypertrophy and congestive heart failure in hypertension treatment trials.

J Am Coll Cardiol 1996; 27: 1214–8.

Hebert

P.R.

, Moser

, Mayer

Recent evidence on drug therapy of mild to moderate hypertension and decreased risk of coronary heart disease.

Arch Intern Med 1993; 153: 578–81.

Tuomilehto

, Rastenyte

, Birkenhager

W.H.

for the Systolic Hypertension in Europe Trial Investigators. Effects of calcium channel blockade in older patients with diabetes and systolic hypertension.

N Engl J Med 1999; 340: 677–84.

Five-year findings of the Hypertension Detection and Follow-Up Program. III. Reduction in stroke incidence among persons with high blood pressure.

JAMA 1982; 247: 633–8.

United Kingdom Prospective Diabetes Study (UKPDS) Group.

Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38.

BMJ 1998; 317: 703–13.

National Center for Health Statistics.

Blood pressure of adults by age and sex, United States, 1960–1962.

Vital Health Stat 1964; 11: 4.

Burt

V.L.

, Cutler

J.A.

, Higgins

Trends in the prevalence, awareness, treatment, and control of hypetension in the adult U.S. population: data from the health examination surveys, 1960 to 1991.

Hypertension 1995; 26: 60–9.

10.

Jones

D.W.

, Hall

J.E.

The National High Blood Pressure Education Program: thirty years and counting.

Hypertension 2002; 39: 941–2.

11.

Julius

, Kjeldsen

S.E.

, Brunner

VALUE Trial: long-term blood pressure trends in 13,449 patients with hypertension and high cardiovascular risk.

Am J Hypertens 2003; 16: 544–8.

12.

Cushman

W.C.

, Ford

C.E.

, Cutler

J.A.

Success and predictors of blood pressure control in diverse North American settings: the antihypertensive and lipid-lowering treatment to prevent heart attack trial (ALLHAT).

J Clin Hypertens 2002; 4: 393–405.

13.

Black

H.R.

, Elliott

W.J.

, Grandits

Principal results of the Controlled Onsent Verapamil Investigation of Cardiovascular End Points (CONVINCE) trial.

JAMA 2003; 289: 2073–82.

14.

Franklin

S.S.

, Jacobs

M.J.

, Wong

N.D.

Predominance of isolated systolic hypertension among middle-aged and elderly US hypertensives: analysis based on National Health and Nutrition Examination Survey (NFIANES) III.

Hypertension 2001; 37: 869–74.

15.

Egan

B.M.

, Lackland

D.T.

, Cutler

N.E.

Awareness, knowledge and attitudes of older Americans about high blood pressure: implications for healthcare policy, education and research.

Arch Intern Med 2003; 163: 681–7.

16.

Hyman

D.J.

, Pavlik

V.N.

Self-reported hypertension treatment practices among primary care physicians.

Arch Intern Med 2000; 160: 2281–6.

17.

Pickering

T.G.

, James

G.D.

, Boddie

How common is white coat hypertension?

JAMA 1988; 259: 225–8.

18.

Mejia

, Egan

, Schork

, Zweifler

Importance of blood pressure measurement artefacts and lack of target organ involvement in the assessment of patients with treatment resistant hypertension.

Ann Intern Med 1990; 112: 270–7.

19.

Brown

M.A.

, Buddie

M.L.

, Martin

Is resistant hypertension really resistant?

Am J Hypertens 2001; 14: 1263–9.

20.

Khattar

R.S.

, Senior

, Lahiri

Cardiovascular outcome in white-coat versus sustained mild hypertension: a 10-year follow-up study.

Circulation 1998; 98: 1892–7.

21.

Staessen

J.A.

, Thijs

, Fagard

Predicting cardiovascular risk using conventional vs ambulatory blood pressure in older patients with systolic hypertension.

JAMA 1999; 282: 539–46.

22.

Clement

D.L.

, DeBuyzere

M.L.

, DeBacquer

D.A.

Prognostic value of ambulatory blood-pressure recordings in patients with treated hypertension.

N Engl J Med 2003; 348: 2407–15.

23.

Thijs

, Staessen

J.A.

, Celis

Reference values for self-recorded blood pressure: a meta-analysis of summary data.

Arch Intern Med 1998; 158: 481–8.

24.

National Heart, Lung, and Blood Institute, National Institutes of Health. The Sixth Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. November 1997. NIH Publication No.: 98–4080. Bestheda (MD): National Institutes of Health; 1997.

25.

Materson

B.J.

, Reda

D.J.

, Preston

R.A.

Response to a second single antihypertensive agent used as monotherapy for hypertension after failure of the initial drug.

Arch Intern Med 1995; 155: 1757–62.

26.

Weber

M.A.

, Drayer

J.I.

Single-agent and combination therapy of essential hypertension.

Am Heart J 1984; 108: 311–6.

27.

Wing

L.M.H.

, Reid

C.M.

, Ryan

A comparison of outcomes with angiotensin-converting-enzyme inhibitors and diuretics for hypertension in the elderly.

N Engl J Med 2003; 348: 583–92.

28.

Laragh

J.H.

Laragh's lessons in renin system pathophysiology for treating hypertension and its fatal cardiovascular consequences. New York: Elsevier Science Inc.; 2002.

29.

Blumenfeld

J.D.

, Laragh

J.H.

Renin system analysis: a rational method for the diagnosis and treatment of the individual patient with hypertension.

Am J Hypertens 1998; 11: 894–6.

30.

Setaro

J.F.

, Black

H.R.

Refractory hypertension: review article.

N Engl J Med 1992; 327: 543–7.

31.

Hyman

D.J.

, Pavlik

V.N.

Characteristics of patients with uncontrolled hypertension in the United States.

N Engl J Med 2001; 345: 479–86.

32.

Franklin

S.S.

, Larson

M.G.

, Khan

S.A.

Does the relation of blood pressure to coronary heart disease risk change with aging? The Framingham Study.

Circulation 2001; 103: 1188–90.

33.

Levy

, Kannel

W.B.

Cardiovascular risk: new insights from Framingham.

Am Heart J 1988; 116(1 Pt 2): 266–72.

34.

Hypertension Detection and Follow-up Program Cooperative Group.

Five-year findings of the Hypertension Detection and Follow-up Program: mortality by race, sex and age.

JAMA 1979; 242: 2572–7.

35.

Weinick

R.M.

, Zuvekas

S.H.

, Cohen

J.W.

Racial and ethnic differences in access to and use of health care services.

Med Care Res Rev 2000; 57 Suppl 1: 36–54.

36.

Cabana

M.D.

, Rand

C.S.

, Powe

N.R.

Why don't physicians follow clinical practice guidelines? A framework for improvement.

JAMA 1999; 282: 1458–65.

37.

Berlowitz

D.R.

, Ash

A.S.

, Hickey

E.C.

Inadequate management of blood pressure in a hypertensive population.

N Engl J Med 1998; 27: 1957–63.

38.

Townsend

R.R.

, Shulkin

D.J.

, Bernard

Improved outpatient hypertension control with disease management guidelines.

Am J Hypertens 1999; 12: 88.

39.

Yegian

J.M.

, Pockell

D.G.

, Smith

M.D.

, Murray

E.K.

The nonpoor uninsured in California, 1998.

Health Aff (Millwood) 2000; 19: 171–7.

40.

Solberg

L.I.

, Brekke

M.L.

, Kottke

T.E.

Are physicians less likely to recommend preventive services to low-SES patients?

Prev Med 1997; 26: 350–7.

41.

Weir

M.R.

, Maibach

E.W.

, Bakris

G.L.

Implications of a health lifestyle and medication analysis for improving hypertension control.

Arch Intern Med 2000; 160: 481–90.

42.

Richardson

M.A.

, Post-White

, Singletary

S.E.

, Justice

Recruitment for complementary/alternative medicine trials: who participates after breast cancer?

Ann Behav Med 1998; 20: 190–8.

43.

Larme

A.C.

, Pugh

J.A.

Attitudes of primary care providers toward diabetes: barriers to guideline implementation.

Diabetes Care 1998; 21: 1391–6.

44.

Langfield

Hypertension: deficient care in the medically served.

Ann Intern Med 1973; 78: 19–23.

45.

Haynes

R.B.

, Taylor

, Sackett

D.L.

Can simple clinical measurements detect patient noncompliance?

Hypertension 1980; 2: 656–64.

46.

Inui

T.S.

, Carter

W.B.

, Pecoraro

R.E.

Screening for noncompliance among patients with hypertension: is self-report the best available measure?

Med Care 1981; 19: 1061–4.

47.

Meland

, Maeland

J.G.

, Laerum

The importance of self-efficacy in cardiovascular risk factor change.

Scand J Public Health 1999; 27: 11–7.

48.

Alexander

, Tekawa

, Hunkeler

Evaluating hypertension control in a managed care setting.

Arch Intern Med 1999; 159: 2673–7.

49.

Ferguson

R.P.

, Wetle

, Dubitzky

, Winsemius

Relative importance to elderly patients of effectiveness, adverse effects, convenience and cost of antihypertensive medications. A pilot study.

Drugs Aging 1994; 4: 56–62.

50.

Lackland

, Egan

, Cheek

, Dunbar

Racial differences in the use of office-based medical services for blood pressure assessment.

Am J Hypertens 1993; 6: 88A.

51.

Wheeler

F.C.

, Lackland

D.T.

, Mace

M.L.

Evaluating South Carolina's community cardiovascular disease prevention project.

Public Health Rep 1991; 106: 536–43.

52.

Kirscht

J.P.

, Rosenstock

I.M.

Patient adherence to antihypertensive medical regimens.

J Community Health 1977; 3: 115–24.

53.

Skelly

A.H.

, Marshall

J.R.

, Haughey

B.P.

Self-efficacy and confidence in outcomes as determinants of self-care practices in inner-city, African-American women with non-insulin-dependent diabetes.

Diabetes Educator 1995; 21: 38–46.

54.

Jackson

A.L.

Operation Sunday School—educating caring hearts to be healthy hearts.

Public Health Rep 1990; 105: 85–8.

55.

Ahluwalia

J.S.

, McNagny

S.E.

, Rask

K.J.

Correlates of controlled hypertension in indigent, inner-city hypertensive patients.

J Gen Intern Med 1997; 23: 7–14.

56.

Shea

, Misra

, Ehrlich

M.H.

Correlates of nonadherence to hypertension treatment in an inner-city minority population.

Am J Public Health 1992; 82: 1607–12.

57.

David

S.K.

, Winkleby

M.A.

, Farquhar

J.W.

Increasing disparity in knowledge of cardiovascular disease risk factors and risk-reduction strategies by socioeconomic status: implications for policymakers.

Am J Prev Med 1995; 11: 318–23.

58.

Gates

, McDonald

Comparison of dietary risk factors for cardiovascular disease in African-American and white women.

J Am Diet Assoc 1997; 97: 1394–400.

59.

Kayrooz

, Moy

T.F.

, Yanek

J.L.

, Becker

D.M.

Dietary fat patterns in urban African-American women.

J Community Health 1998; 23: 453–69.

60.

Karanza

N.M.

, McCullough

M.L.

, Kumanyika

S.K.

Pre-enrollment diets of Dietary Approaches to Stop Hypertension trial participants.

J Am Diet Assoc 1998; 99(8 Suppl): S28–34.

61.

Keli

S.O.

, Hertog

M.G.L.

, Feskens

E.J.M.

, Kromhout

Dietary flavonoids, antioxidant vitamins and incidence of stroke.

Arch Intern Med 1996; 154: 637–42.

62.

Joshipura

K.J.

, Ascherio

, Manson

I.E.

Fruit and vegetable intake in relation to risk of ischemic stroke.

JAMA 1999; 282: 1233–9.

63.

Appel

J.L.

, Moore

T.J.

, Obarzanek

A clinical trial of the effects of dietary patterns on blood pressure.

N Engl J Med 1997; 336: 1117–24.

64.

Svetkey

L.P.

, Moore

T.J.

, Simons-Morton

D.G.

Angiotensinogen genotype and blood pressure response in the Dietary Approaches to Stop Hypertension (DASH) study

J Hypertens 2001; 19: 1949–56.

65.

DiMatteo

M.R.

, Lepper

H.S.

, Croghan

T.W.

Depression is a risk factor for noncompliance with medical treatment.

Arch Intern Med 2000; 160: 2101–7.

66.

Lang

, Degoulet

, Aime

Relationship between alcohol consumption and hypertension prevalence and control in a French population.

J Chron Dis 1987; 40: 713–20.

67.

Andrus

M.R.

, Roth

M.T.

Health literacy: a review.

Pharmacotherapy 2002; 22: 282–302.

68.

Weiss

B.D.

Health literacy: an important issue for communicating health information to our patients.

Chin Med J (Engl) 2001; 64: 603–8.

69.

Parikh

N.S.

, Parker

R.M.

, Nurss

J.R.

Shame and health literacy: the unspoken connection.

Pat Educ Couns 1996; 27: 33–9.

70.

van der Pol

, Cairns

Estimating time preferences for health using discrete choice experiments.

Soc Sci Med 2001; 52: 1459–70.

71.

Enemark

, Lyttkens

C.H.

, Troeng

Implicit discount rates of vascular surgeons in the management of abdominal aortic aneurysms.

Med Decis Making 1998; 18: 168–77.

72.

Ganiats

T.G.

, Carson

R.T.

, Hamm

R.M.

Population-based time preferences for future health outcomes.

Med Decis Making 2000; 20: 263–70.

73.

Chapman

G.B.

Temporal discounting and utility for health and money.

J Exp Psychol Learn Mem Cogn 1996; 22: 771–91.

74.

West

R.R.

Discounting the future: influence of the economic model.

J Epidemiol Community Health 1996; 50: 239–44.

75.

Parsonage

, Neuburger

Discounting and health benefits.

Health Econ 1992; 1: 71–6.

76.

Sanson-Fisher

R.W.

, Campbell

E.M.

, Redman

, Hennrikus

D.J.

Patient-provider interactions and patient outcomes.

Diabetes Educator 1989; 15: 134–8.

77.

Shank

J.C.

, Powell

, Llewelyn

A five-year demonstration project associated with improvement in physician health maintenance behavior.

Fam Med 1989; 21: 273–8.

78.

Sciamanna

C.N.

, Tate

D.F.

, Lang

, Wing

R.R.

Who reports receiving advice to lose weight? Results from a multistate survey.

Arch Intern Med 2000; 160: 2334–9.

79.

Ruggiero

, Rossi

J.S.

, Prochaska

J.O.

Smoking and diabetes: readiness for change and provider advice.

Addict Behav 1999; 24: 573–8.

80.

Schoenberger

J.A.

Topics in hypertension: patient compliance in antihypertensive therapy New York: American Society of Hypertension; 1997.

81.

Dunbar

J.M.

, Stunkard

A.J.

Adherence to diet and drug regimen. In: Levy

, Rifkin

, Dennis

, Ernst

editors. Nutrition, lipids and coronary heart disease. New York: Raven Press; 1979. p. 391–423.

82.

Beesesen

D.H.

Applying stages of change theory to office-based counseling. In: Beesesen

D.H.

, Kushner

editors. Evaluation and management of obesity. Philadelphia: Hanley & Belfus; 2002. p. 33–9.

83.

Diehl

N.S.

, Evenson

K.R.

Exercise: getting your patient going in 3 minutes or less. In: Egan

B.M.

, Basile

J.N.

, Lackland

D.T.

editors. Hot topics in hypertension: a TRIP with the experts. Philadelphia: Hanley & Belfus; 2003. [In press]

84.

Ruzicka

, Leenen

F.H.H.

Monotherapy versus combination therapy as first line treatment of uncomplicated arterial hypertension.

Drugs 2001; 61: 944–54.

85.

Ashida

, Sugiyama

, Okuno

Relationship between home blood pressure measurement and medication compliance and name recognition of antihypertensive drugs.

Hypertens Res Clin Exp 2000; 23: 21–4.

86.

Johnson

A.L.

, Taylor

, Sackett

D.L.

Self-recording of blood pressure in the management of hypertension.

Can Med Assoc J 1978; 119: 1034–9.

87.

Mehos

B.M.

, Saseen

J.J.

, MacLaughlin

E.F.

Effect of pharmacist intervention and initiation of home blood pressure monitoring in patients with uncontrolled hypertension.

Pharmacotherapy 2000; 20: 1384–9.

88.

Rogers

M.A.

, Small

, Buchan

D.A.

Home monitoring service improves mean arterial pressure in patients with essential hypertension. A randomized, controlled trial.

Ann Intern Med 2001; 134: 1024–32.

89.

Frishman

W.H.

Effects of nonsteroidal anti-inflammatory drug therapy on blood pressure and peripheral edema.

Am J Cardiol 2002; 89(6A): 18D–25D.

90.

Blackshear

J.L.

, Schwartz

G.L.

Step care therapy for hypertension in diabetic patients.

Mayo Clin Proc 2001; 76: 1266–74.

91.

Brown

C.M.

, Segal

The effects of health and treatment perceptions on the use of prescribed medication and home remedies among African-American hypertensives.

Soc Sci Med 1996; 43: 903–17.

92.

McDonald

H.P.

, Garg

A.X.

, Haynes

R.B.

Interventions to enhance patient adherence to medication prescriptions: scientific review.

JAMA 2002; 288: 2868–79.

93.

Haynes

R.B.

, McDonald

H.P.

, Garg

A.X.

Helping patients follow prescribed treatment.

JAMA 2002; 288: 2880–3.

94.

Inui

T.S.

, Yourtee

E.L.

, Williamson

J.W.

Improved outcomes in hypertension after physician tutorials: a controlled trial.

Ann Intern Med 1976; 84: 646–51.

95.

Keller

V.F.

, Carroll

J.G.

A new model for physician-patient communication.

Pat Educ Couns 1994; 23: 131–40.

96.

Ryan

, Carr

A study of the differential effects of Tomm's questioning styles on therapeutic alliance.

Fam Process 2001; 40: 67–77.

97.

Hall

J.A.

, Roter

D.L.

, Katz

N.R.

Meta-analysis of correlates of provider behavior in medical encounters.

Med Care 1988; 26: 657–75.

98.

Isaksson

Ö. stergren

Prognosis in therapy-resistant hypertension.

J Intern Med 1994; 236: 643–9.

99.

MacMahon

, Peto

, Cutler

Blood pressure, stroke, and coronary heart disease. Part 1: prolonged differences in blood pressure: prospective observational studies corrected for regression dilution bias.

Lancet 1990; 335: 765–74.

100.

Egan

B.M.

, Lackland

D.T.

, Basile

J.N.

American Society of Hypertension regional chapters: leveraging the impact of the clinical hypertension specialist in the local community.

Am J Hypertens 2002; 15: 372–9.